Skip to main content
Equibles

RAYMOND JAMES FINANCIAL INC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 720005 ST. PETERSBURG, FL
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$28,390,172
+$9,613,156 QoQ
Shares Held
362,721
+24.8% QoQ
Ownership
0.320%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#65
of 667 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 19% Shared 0% None 81%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RAYMOND JAMES FINANCIAL INC holds $1,702,332,948 across 201 Biotechnology names. HALO ranks #16 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 556,876 $276,617,014
2 ALNY
Alnylam Pharmaceuticals, Inc.
 392,799 $118,244,281
3 REGN
Regeneron Pharmaceuticals, Inc.
 172,896 $107,807,571
4 RPRX
Royalty Pharma plc
 1,599,881 $89,705,325
5 INSM
INSMED Inc
 660,601 $70,433,276
6 KRYS
Krystal Biotech, Inc.
 158,675 $58,974,733
7 JAZZ
Jazz Pharmaceuticals plc
 228,645 $55,096,584
8 EXEL
Exelixis, Inc.
 941,571 $51,230,875

All Filings in HALO

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,390,172 362,721
2026-03-31 $18,777,016 290,531
2025-12-31 $19,041,457 282,934
2025-09-30 $20,641,320 281,447
2025-06-30 $13,129,898 252,401
2025-03-31 $19,575,566 306,779
2024-12-31 $21,838,363 456,774